[1] Ohata T, Yoshida K, Sakai H, Hamanoue H, Mizuguchi T, Shimizu Y, Okano T, Takada F, Ishikawa K, Mizusawa H, Yoshiura KI, Fukushima Y, Ikeda SI, Matsumoto N (2006) A-16C>T substitution in the 5' UTR of the puratrophin-1 gene is prevalent in autosomal dominant cerebellar ataxia in Nagano. J Hum Genet 51:461-466
[2] Owada K, Ishikawa K, Toru S, Ishida G, Gomyoda M, Tao O, Noguchi Y, Kitamura K, Kondo I, Noguchi E, Arinami T, Mizusawa H (2005) A clinical, genetic, and neuropathologic study in a family with 16q-linked ADCA Type Ⅲ. Neurology 65: 629-632
[3] Sato N, Amino T, Kobayashi K, Asakawa S, Ishiguro T, Tsunemi T, Takahashi M, Matsuura T, Flanigan KM, Iwasaki S, Ishino F, Saito Y, Murayama S, Yoshida M, Hashizume Y, Takahashi Y, Tsuji S, Shimizu N, Toda T, Ishikawa K, Mizusawa H (2009) Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. Am J Hum Genet 85:544-557
[4] Shimizu K, Hanajima R, Satou S, Shimizu T, Watanabe K, Kaneko A, Iizuka T, Nishiyama K (2017) Holmes’s tremor caused by coexisting Parkinson’s disease in a case of spinocerebellar ataxia type 31. Neurol Clin Neurosci 5:71-72
[5] Saito R, Kikuno S, Maeda M, Uesaka Y, Ida M (2014) A case of 77-year-old male with spinocerebellar ataxia type 31 with left dominant dystonia. Rinsho Shinkeigaku 54:643-647
[6] Hasegawa A, Koike R, Koh K, Kawakami A, Hara N, Takiyama Y, Ikeuchi T (2017) Co-existence of spastic paraplegia-30 with novel KIF1A mutation and spinocerebellar ataxia 31 with intronic expansion of BEAN and TK2 in a family. J Neurol Sci 372:128-130
[7] Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson's disease Mov Disord 30:1591-1601
[8] Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group (2017) Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord 32: 853-864
[9] Mukai M, Sugaya K, Yabe I, Goto Y, Yokochi F, Miyamoto K, Cai H, Sasaki H, Matsubara S (2013) Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a Y955C mutation in POLG1. Park Relat Disord 19:821-824
[10] Aoki K, Kawata A, Suda M, Hirai S (2001) Clinical features of autosomal dominant spinocerebellar ataxias genetically unclassified into any known triplet-repeat diseases. Rinsho Shinkeigaku 41:18-23
[11] Ishikawa K, Toru S, Tsunemi T, Li M, Kobayashi K, Yokota T, Amino T, Owada K, Fujigasaki H, Sakamoto M, Tomimitsu H, Takashima M, Kumagai J, Noguchi Y, Kawashima Y, Ohkoshi N, Ishida G, Gomyoda M, Yoshida M, Hashizume Y, Saito Y, Murayama S, Yamanouchi H, Mizutani T, Kondo I, Toda T, Mizusawa H (2005) An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5’untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains. Am J Hum Genet 77:280–296
[12] Sakai H, Yoshida K, Shimizu Y, Morita H, Ikeda S, Matsumoto N (2010) Analysis of an insertion mutation in a cohort of 94 patients with spinocerebellar ataxia type 31 from Nagano, Japan. Neurogenetics 11:409–415
[13] Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050-2055
[14] Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246:214-221
[15] Hotter A, Esterhammer R, Schocke MF, Seppi K (2009) Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord 24(suppl 2):S711-720
[16] Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jäger HR (2012) Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 27:1754-1762
[17] Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129:1040-1049
[18] Choi SM, Kim BC, Nam TS, Kim JT, Lee SH, Park MS, Kim MK, de Leon MJ, Cho KH (2011) Midbrain atrophy in vascular Parkinsonism. Eur Neurol 65:296-301
[19] Wojciechowska M, Krzyzosiak WJ (2011) Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet 20:3811-3821
[20] Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, Renoux AJ, Chen KC, Scaglione KM, Basrur V, Elenitoba-Johnson K, Vonsattel JP, Louis ED, Sutton MA, Taylor JP, Mills RE, Charlet-Berguerand N, Paulson H (2013) CGG repeat-associated translation mediates neurodegeneration in Fragile X tremor ataxia syndrome. Neuron 78:440-455
[21] Jain A, Vale RD (2017) RNA phase transitions in repeat expansion disorders. Nature 546:243-247
[22] Saha S, Hyman AA (2017) RNA gets in phase. J Cell Biol 216:2235-2237
[23] Ishiguro T, Sato N, Ueyama M, Fujikake N, Sellier C, Kanegami A, Tokuda E, Zamiri B, Gall-Duncan T, Mirceta M, Furukawa Y, Yokota T, Wada K, Taylor JP, Pearson CE, Charlet-Berguerand N, Mizusawa H, Nagai Y, Ishikawa K (2017) Regulatory role of RNA chaperone TDP-43 for RNA misfolding and repeat-associated translation in SCA31. Neuron 94:108-124
[24] Rayaprolu S, Fujioka S, Traynor S, Soto-Ortolaza AI, Petrucelli L, Dickson DW, Rademakers R, Boylan KB, Graff-Radford NR, Uitti RJ, Wszolek ZK, Ross OA (2013) TARDBP mutations in Parkinson’s disease. Park Relat Disord 19:312-315
[25] Merner ND, Girard SL, Catoire H, Bourassa CV, Belzil VV, Rivière JB, Hince P, Levert A, Dionne-Laporte A, Spiegelman D, Noreau A, Diab S, Szuto A, Fournier H, Raelson J, Belouchi M, Panisset M, Cossette P, Dupré N, Bernard G, Chouinard S, Dion PA, Rouleau GA (2012) Exome sequencing identifies FUS mutations as a cause of essential tremor. Am J Hum Genet 91:313-319
[26] Ma D, Tan YJ, Ng ASL, Ong HL, Sim W, Lim WK, Teo JX, Ng EYL, Lim EC, Lim EW, Chan LL, Tan LCS, Yi Z, Tan EK (2020) Association of NOTCH2NLC repeat expansions with Parkinson disease. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.3023
[27] Shi CH, Fan Y, Yang J, Yuan YP, Shen S, Liu F, Mao CY, Liu H, Zhang S, Hu ZW, Fan LY, Li MJ, Fan SH, Liu XJ, Xu YM, NOTCH2NLC (2020) Intermediate-Length Repeat Expansions Are Associated with Parkinson Disease. Ann Neurol. https://doi.org/10.1002/ana.25925
[28] De Pablo-Fernandez E, Doherty KM, Holton JL, Revesz T, Djamshidian A, Limousin P, Bhatia KP, Warner TT, Lees AJ, Ling H (2015) Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases. J Neurol Neurosurg Psychiatry 86:934-936
[29] Paucar M, Beniaminov S, Paslawski W, Svenningsson P (2016) PSP-CBS with dopamine deficiency in a female with a FMR1 premutation. Cerebellum 15:636-640
[30] Salomão RPA, Vale TC, Marussi VHR, Barsottini OGP, Pedroso JL (2019) Late-onset hummingbird sign in a woman with fragile X premutation. J Neurol Sci 403:75-77.